Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Products>This Product

PerkinElmer Launches the New Spectrum Two™ Spectrometer for High-Speed Infrared Analysis

Product Image
Product Description

PerkinElmer Inc. announces the launch of Spectrum Two™, a reliable infrared (FT-IR) spectrometer built upon decades of spectroscopy expertise. Part of a new platform of FT-IR spectrometers, Spectrum Two is designed specifically to perform rapid analytical measurements and is suited to a wide range of materials and markets.

Easy to use and compact, Spectrum Two is ideal for unknown substance identification, material qualification or concentration determination.  Spectrum Two can be operated across applications as diverse as fuel and lubricant analysis, pharmaceutical, nutraceutical, environmental and polymer analysis, and the teaching of these methods in academic laboratories.

The instrument's low-maintenance design breaks new ground in operational simplicity and is intended for use by "anyone, anywhere, anytime" - bringing the benefits of accurate and reliable high-speed FT-IR analysis to non-expert users, even in non-laboratory environments.

Dusty Tenney, president, Analytical Sciences and Laboratory Services, PerkinElmer, stated, “More than 65 years of PerkinElmer spectroscopy knowledge have been distilled into Spectrum Two to provide an instrument that verifies the quality of materials – fast. This out-of-the-box solution meets the exacting requirements of many applications and will grant customers absolute confidence in their infrared results."

Dedicated systems utilizing Spectrum Touch™ next-generation user interface have also been developed to meet the needs of application-specific quality control analysis. Incorporating user-friendly touchscreen technology, Spectrum Touch allows results to be obtained faster than ever before by even the most inexperienced user, simplifying analysis operations considerably.

The instrument's innovative software and patented features ensure consistency and repeatability, and a unique humidity shield protects against environmental effects.

The Spectrum Two analyzers also represent a major milestone of PerkinElmer's Corporate Social Responsibility initiative, through reduction of the overall carbon footprint of manufacture, packaging and transportation. These are the first PerkinElmer instruments where reducing the impact on the environment was integral to the design process, by creating the smallest and lightest PerkinElmer infrared instruments ever made and selecting materials from recyclable sources.   This design philosophy will also help customers reduce their own carbon footprint and operating costs by minimizing the instruments’ power consumption.
For further information on PerkinElmer’s infrared spectroscopy solutions, please visit

Product PerkinElmer Launches the New Spectrum Two™ Spectrometer for High-Speed Infrared Analysis
Company PerkinElmer
Price Request a quote
More Information View company product page
Catalog Number L160000A
Quantity Unspecified
Company Logo

940 Winter Street Waltham Massachusetts 02451 USA

Tel: +1-203-925-4602
Fax: +1-203-944-4904

Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos